Global Microbial Products Market was valued US$ X.20 Bn 2019 and is expected to reach US$ XX Bn by 2027, at a CAGR of XX% during a forecast period.
Microbial products are extensively utilized in fermentation processes for the commercial production of microbial products like antibiotics, nutrients such as amino acids, vitamins, and organic acids, chemotherapeutic agents, vaccines. The main categories of microbial products are bacteria, viruses, fungi, molds and yeasts.
The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.
The report analyzes factors affecting microbial products market from both demand and supply side and further estimates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The agriculture industry is mounting with increasing the demand for microbial products. As per the MMR research, the agriculture industry is growing with the CAGR rate of ~7% in 2018 and it is generating the demand for all the products associated with agriculture. Also, the food and additives industry boosting the growth of the market owing to the increasing demand for dairy products.
The production of enzymes for end-use industries such as paper, leather, and food preservation is impelling the growth of the market. Healthcare and agriculture products with the help of genetic recombinant technology are boosting to produce more environmental-friendly and cost-effective products. Rising demand for microbial products for clinical diagnostics products is a key factor fueling the global microbial products market.
In July 2019, DMC has managed to raise Series, equity financing backed by the support of Sofinnova Partners. The former will be using its technology to bring down biological complexity and also accelerate the speed of development. This will lead to low cost and fermentation-based manufacturing platform with the capability of generating a wide range of microbial products.
Microbial Products Market Segment analysis
In terms of source, bacterial segment is expected to dominate the market during the forecast year. Bacteria cultures is widely used in research institutes and industrial application, include methicillin-resistant/sensitive research materials, quality control organisms for commercial identification systems, a wide selection of extremophile strains from a variety of environmental sources, and genomic DNA from well-characterized microbial strains suitable for amplification by PCR technique. Furthermore various bacterial specie, anaerobic bacteria, bacterial genome sequencing strain, are some techniques and culture method which is adopted by various industries for their research and development purpose, is expected to fuel the market in future.
Microbial Products Market Regional Analysis
Regionally, North America is projected to witness the fastest growth during the forecast period. Factors like outstanding reimbursement, advancement in technology for R&D, high expenditure on healthcare sector. Microbial products are highly getting utilized in U.S because of, recent developed technologies for microbiology is expected to fuel the market in North America region. Furthermore, Europe is considered as a second largest region as consumption of microbial product is growing.
The objective of the report is to present a comprehensive analysis of the Global Microbial Products Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding Global Microbial Products Market dynamics, structure by analyzing the market segments and project the Global Microbial Products Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Microbial Products Market make the report investor’s guide.
Scope of Global Microbial Products Market
Global Microbial Products Market, By Type
• Chemotherapeutic Agents
Global Microbial Products Market, By Application
Global Microbial Products Market, By Source
Global Microbial Products Market, By End-User
• Pharmaceutical and Biotechnological Industries
• Hospitals and Clinics
• Diagnostic Labs
• Research and Academics
Global Microbial Products Market, By Regions
• North America
• Latin America
• Middle East and Africa (MEA)
Key Players Operating the Global Microbial Products Market
• Kyowa Hakko Bio Co.
• GlaxoSmithKline plc,
• NovaDigm Therapeutics
• Sanofi S.A
• Novartis AG
• Merck & Co. Inc.
• Valent BioSciences Corp.
• Amgen Inc.
• Pfizer Inc., Ltd
• Biomérieux SA
• Ajinomoto Co. Inc.
• Certis Usa
• Durect Corp.
• Earthrise Nutritionals Llc
• Energy Derived
• Environmental Biotechnologies Inc.
• Genzyme Corp
Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Name: Vikas Godage
Organization: Maximize Market Research Pvt.Ltd.Pune
Contact: +919607065656 / +919607195908